# LMMY (Exousia Bio, Inc.) - SEC EDGAR Financial Statements

> Exousia Bio, Inc. reported $0 in revenue and a net loss of $99K for the trailing twelve months ended February 28, 2026 (down 67.4% year over year).

- Canonical: https://convexityos.com/fundamentals/LMMY
- Markdown: https://convexityos.com/fundamentals/LMMY.md
- SEC CIK: 0001939937
- Reporting currency: USD
- Latest filing period: February 28, 2026
- Last synced: Nov 21, 2026, 05:14 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001939937&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $0 | -67.4% YoY |
| Operating Income | TTM | -$534K | Operating profit |
| Net Income | TTM | -$99K | GAAP bottom line |
| Diluted EPS | TTM | -$0.01 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Feb 28, 2026 | -- | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Revenue** | $3.8K | $12K | $0 |
| Cost of Revenue | $7.3K | $9.7K | $0 |
| **Gross Profit** | -$3.5K | $1.8K | $0 |
| Total Operating Expenses | $32K | $28K | $56K |
| **Operating Income** | -$35K | -$26K | -$56K |
| **EBITDA** | -$24K | -$12K | -$42K |
| Income Before Tax | $51K | -$26K | -$56K |
| Income Tax Expense | $0 | $0 | $0 |
| **Net Income** | $51K | -$26K | -$56K |
| Basic EPS | $0.00 | $0.00 | $0.00 |
| **Diluted EPS** | $0.00 | $0.00 | $0.00 |
| Basic Shares Outstanding | 7.8M | 7.8M | 5.7M |
| Diluted Shares Outstanding | 7.8M | 7.8M | 5.7M |

### Income Statement (Quarterly)

| Line Item | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $0 | $0 | $0 | $3.8K | $3.8K |
| Cost of Revenue | $62K | $62K | $0 | $7.3K | $0 | $0 | $0 | -- |
| **Gross Profit** | -$62K | -$62K | $0 | -$7.3K | $0 | $0 | $3.8K | -$5.9K |
| Selling, General & Admin | -- | $0 | -- | -- | -- | $7.0K | -- | -- |
| Total Operating Expenses | $175K | $175K | $32K | $21K | $7.0K | $7.0K | $8.1K | -$228 |
| **Operating Income** | -$237K | -$237K | -$32K | -$28K | $7.0K | $7.0K | -$4.3K | -$5.7K |
| **EBITDA** | -$237K | -$236K | -$32K | -$25K | $7.0K | $11K | $1.8K | -$2.0K |
| Interest Income | -- | -- | $0 | -- | -- | -- | $431 | -- |
| Income Before Tax | -$19K | -$19K | -$32K | -$29K | $80K | $80K | -$3.9K | -$5.3K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$19K | -$19K | -$32K | -$29K | $80K | $80K | -$3.9K | -$5.3K |
| Basic EPS | $0.00 | $0.00 | $0.00 | -- | $0.01 | $0.01 | $0.00 | -- |
| **Diluted EPS** | $0.00 | $0.00 | $0.00 | -- | $0.01 | $0.01 | $0.00 | -- |
| Basic Shares Outstanding | 16.8M | 16.8M | 7.8M | -- | 7.8M | 7.8M | 7.8M | -- |
| Diluted Shares Outstanding | 16.8M | 16.8M | 7.8M | -- | 7.8M | 7.8M | 7.8M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | -- | $7.9K | $10K |
| **Cash & Short-Term Investments** | -- | -- | $7.9K | $10K |
| Accounts Receivable, Net | $0 | $12K | $0 | -- |
| **Total Current Assets** | $0 | $13K | $7.9K | $10K |
| Property, Plant & Equipment, Net | $0 | $5.0K | $10.0K | $15K |
| Intangible Assets | $0 | $9.5K | $19K | $29K |
| Other Non-Current Assets | $0 | -- | -- | -- |
| **Total Non-Current Assets** | $0 | $14K | $29K | $44K |
| **Total Assets** | $0 | $27K | $37K | $54K |
| Accounts Payable | $0 | -- | -- | -- |
| Other Current Liabilities | $0 | -- | -- | -- |
| **Total Current Liabilities** | $0 | $14K | $3.6K | $0 |
| **Total Non-Current Liabilities** | $0 | $68K | $63K | $54K |
| **Total Liabilities** | $0 | $82K | $66K | $54K |
| Common Stock | $778 | $778 | $778 | $500 |
| Retained Earnings | -$32K | -$83K | -$57K | -$937 |
| **Total Stockholders' Equity** | $0 | -$55K | -$29K | -$437 |
| Total Equity | $0 | -$55K | -$29K | -$437 |

### Balance Sheet (Quarterly)

| Line Item | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Accounts Receivable, Net | $0 | $0 | $0 | $0 | $0 | $15K | $15K | $12K |
| **Total Current Assets** | $0 | $0 | $0 | $0 | $0 | $18K | $17K | $13K |
| Property, Plant & Equipment, Net | $670 | $670 | $0 | $0 | $0 | $2.4K | $3.7K | $5.0K |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $4.7K | $7.1K | $9.5K |
| Other Non-Current Assets | $22.05M | $22.05M | -- | $0 | -- | -- | -- | -- |
| **Total Non-Current Assets** | $22.05M | $22.05M | $0 | $0 | $0 | $7.1K | $11K | $14K |
| **Total Assets** | $22.05M | $22.05M | $0 | $0 | $0 | $25K | $28K | $27K |
| Accounts Payable | $212K | $212K | -- | $0 | -- | -- | -- | -- |
| Other Current Liabilities | $1.0K | $1.0K | -- | $0 | -- | -- | -- | -- |
| **Total Current Liabilities** | $261K | $261K | $35K | $0 | $0 | $0 | $17K | $14K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $70K | $68K |
| **Total Liabilities** | $261K | $261K | $35K | $0 | $0 | $0 | $87K | $82K |
| Common Stock | $7.3K | $7.0K | $778 | $778 | $778 | $778 | $778 | $778 |
| Retained Earnings | -$289K | -$289K | -$64K | -$32K | -$28K | -$3.4K | -$87K | -$83K |
| **Total Stockholders' Equity** | $21.79M | $21.79M | -$35K | $0 | $25K | $25K | -$59K | -$55K |
| Total Equity | $21.79M | $21.79M | -$35K | $0 | $25K | $25K | -$59K | -$55K |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Net Income | $51K | -$26K | -$56K |
| Depreciation & Amortization | $11K | $15K | $15K |
| Change in Receivables | $12K | -$12K | $0 |
| **Operating Cash Flow** | -$4.5K | -$12K | -$38K |
| **Investing Cash Flow** | $0 | $0 | $0 |
| Common Stock Issued | $0 | $0 | $28K |
| **Financing Cash Flow** | $3.5K | $5.7K | $36K |
| **Net Change in Cash** | -$1.0K | -$6.8K | -$2.3K |

### Cash Flow Statement (Quarterly)

| Line Item | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$19K | -$19K | -$32K | -$29K | $80K | $80K | -$3.9K | -$5.3K |
| Depreciation & Amortization | $0 | $568 | $0 | $3.7K | $0 | $3.7K | $6.1K | $3.7K |
| **Operating Cash Flow** | $0 | $173K | $3.5K | -$91K | $0 | $90K | -$3.7K | -$1.4K |
| **Investing Cash Flow** | $0 | -$22.05M | $0 | $0 | $0 | -$3.7K | $3.7K | $0 |
| Common Stock Issued | -- | -- | -- | $0 | $0 | $0 | $0 | $0 |
| **Financing Cash Flow** | $0 | $21.88M | -$3.5K | $90K | $0 | -$87K | $0 | $1.4K |
| **Net Change in Cash** | $0 | $0 | $0 | -$1.0K | $0 | $0 | $0 | $2 |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Gross Margin** | -93.4% | 15.9% | -- |
| **Operating Margin** | -942.5% | -228.2% | -- |
| **Net Profit Margin** | 1370.5% | -224.4% | -- |
| Return on Assets (ROA) | -- | -94.0% | -152.3% |
| Current Ratio | -- | 0.91x | 2.18x |
| Quick Ratio | -- | -- | 2.18x |
| **Revenue Growth (YoY)** | -67.4% | -- | -- |
| Gross Profit Growth (YoY) | -291.0% | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -93.4% | -28.9% | 15.0% | 36.6% | 15.9% |
| **Operating Margin** | -- | -- | -- | -502.5% | 52.4% | -103.3% | -171.6% | -295.6% |
| **Net Profit Margin** | -- | -- | -- | 3388.9% | 2014.6% | 581.5% | -115.1% | -224.4% |
| Return on Equity (ROE) | -0.5% | 0.0% | -- | -- | 607.9% | 266.1% | -- | -- |
| Return on Assets (ROA) | -0.5% | 0.0% | -- | -- | -- | 266.1% | -62.8% | -94.0% |
| Current Ratio | 0.00x | 0.00x | 0.00x | -- | -- | -- | 1.00x | 0.91x |
| **Revenue Growth (YoY)** | -- | -- | -100.0% | -100.0% | -100.0% | -100.0% | -- | -- |
| Gross Profit Growth (YoY) | -- | -- | -100.0% | -- | -100.0% | -100.0% | -- | -- |
| Operating Income Growth (YoY) | -3495.0% | -3495.0% | -- | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -123.8% | -123.8% | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -100.0% | -100.0% | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | +91.9% | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
